Drug Target Pharmacogenomics
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in American Journal of PharmacoGenomics
- Vol. 1 (4) , 271-281
- https://doi.org/10.2165/00129785-200101040-00004
Abstract
Pharmacogenomics is a field aimed at understanding the genetic contribution to variability in drug efficacy and toxicity. The goal is to be able to select the drugs with the greatest likelihood of...Keywords
This publication has 68 references indexed in Scilit:
- Pharmacogenomics: The Inherited Basis for Interindividual Differences in Drug ResponseAnnual Review of Genomics and Human Genetics, 2001
- Clinical application of pharmacogeneticsTrends in Molecular Medicine, 2001
- β 2 -Adrenoceptor Polymorphism Determines Vascular Reactivity in HumansHypertension, 2000
- Bradykinin B 2 Receptor Gene Polymorphism Is Associated With Angiotensin-Converting Enzyme Inhibitor–Related CoughHypertension, 2000
- Association of the G s α Gene With Essential Hypertension and Response to β-BlockadeHypertension, 1999
- β-2 Adrenergic Receptor Variants Affect Resting Blood Pressure and Agonist-Induced Vasodilation in Young Adult CaucasiansHypertension, 1999
- Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression.Journal of Clinical Investigation, 1998
- Angiotensin-converting enzyme gene polymorphism and reversibility of uremic left ventricular hypertrophy following long-term antihypertensive therapyKidney International, 1998
- Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studiesJournal Of Hypertension, 1996
- Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapyAtherosclerosis, 1995